Alterity targets MSA treatment breakthrough
Special Report: In a field where treatment options are limited and rapid disease progression remains difficult to manage, Alterity Therapeutics is aiming to shift the narrative for patients with Multiple System Atrophy. Alterity’s phase II drug candidate …